ArticleImmuno-oncology technology2026

Fresh-blood immune profiling of immune-related adverse events in real-world patients identifies organ-specific and steroid responsiveness signatures.

M Velasco Santiago et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.